Defunct Company
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
35
NCT02354781
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Phase: Phase 1/2
Role: Collaborator
Start: Jan 31, 2015
Completion: Nov 30, 2017
NCT02477449
Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers
Phase: Phase 1
Start: Mar 31, 2015
Completion: Oct 31, 2015
NCT02893995
Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
Phase: Phase 4
Start: Feb 28, 2017
Completion: Apr 30, 2018
NCT02882126
An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
Start: Jun 30, 2017
Completion: Jun 30, 2021